These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 27196002)

  • 1. Exosome-mediated small RNA delivery for gene therapy.
    Zhou Y; Zhou G; Tian C; Jiang W; Jin L; Zhang C; Chen X
    Wiley Interdiscip Rev RNA; 2016 Nov; 7(6):758-771. PubMed ID: 27196002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Exosome-Mediated Small RNA Delivery For Gene Therapy].
    Sun W; Cao FJ; Wang N; Zhou Y; Ba Y; Zhang CY
    Sheng Li Ke Xue Jin Zhan; 2016 Jun; 47(3):162-7. PubMed ID: 29888878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SELEX-Based Screening of Exosome-Tropic RNA.
    Yamashita T; Shinotsuka H; Takahashi Y; Kato K; Nishikawa M; Takakura Y
    Biol Pharm Bull; 2017; 40(12):2140-2145. PubMed ID: 29199238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exosome-based small RNA delivery: Progress and prospects.
    Lu M; Xing H; Xun Z; Yang T; Ding P; Cai C; Wang D; Zhao X
    Asian J Pharm Sci; 2018 Jan; 13(1):1-11. PubMed ID: 32104373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosomes as therapeutics: The implications of molecular composition and exosomal heterogeneity.
    Ferguson SW; Nguyen J
    J Control Release; 2016 Apr; 228():179-190. PubMed ID: 26941033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosomes: Therapy delivery tools and biomarkers of diseases.
    Barile L; Vassalli G
    Pharmacol Ther; 2017 Jun; 174():63-78. PubMed ID: 28202367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing exosome-like vesicles with liposomes for the functional cellular delivery of small RNAs.
    Stremersch S; Vandenbroucke RE; Van Wonterghem E; Hendrix A; De Smedt SC; Raemdonck K
    J Control Release; 2016 Jun; 232():51-61. PubMed ID: 27072025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delivery of Small Interfering RNA to Inhibit Vascular Endothelial Growth Factor in Zebrafish Using Natural Brain Endothelia Cell-Secreted Exosome Nanovesicles for the Treatment of Brain Cancer.
    Yang T; Fogarty B; LaForge B; Aziz S; Pham T; Lai L; Bai S
    AAPS J; 2017 Mar; 19(2):475-486. PubMed ID: 27882487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosome as a Novel Shuttle for Delivery of Therapeutics across Biological Barriers.
    Das CK; Jena BC; Banerjee I; Das S; Parekh A; Bhutia SK; Mandal M
    Mol Pharm; 2019 Jan; 16(1):24-40. PubMed ID: 30513203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exosomal RNA as biomarkers and the therapeutic potential of exosome vectors.
    Lässer C
    Expert Opin Biol Ther; 2012 Jun; 12 Suppl 1():S189-97. PubMed ID: 22506888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosome-mediated delivery of siRNA in vitro and in vivo.
    El-Andaloussi S; Lee Y; Lakhal-Littleton S; Li J; Seow Y; Gardiner C; Alvarez-Erviti L; Sargent IL; Wood MJ
    Nat Protoc; 2012 Dec; 7(12):2112-26. PubMed ID: 23154783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted therapeutic delivery using engineered exosomes and its applications in cardiovascular diseases.
    Xitong D; Xiaorong Z
    Gene; 2016 Jan; 575(2 Pt 2):377-384. PubMed ID: 26341056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosomes are natural carriers of exogenous siRNA to human cells in vitro.
    Shtam TA; Kovalev RA; Varfolomeeva EY; Makarov EM; Kil YV; Filatov MV
    Cell Commun Signal; 2013 Nov; 11():88. PubMed ID: 24245560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosomes and the emerging field of exosome-based gene therapy.
    O'Loughlin AJ; Woffindale CA; Wood MJ
    Curr Gene Ther; 2012 Aug; 12(4):262-74. PubMed ID: 22856601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological characteristics of exosomes and genetically engineered exosomes for the targeted delivery of therapeutic agents.
    Lin Y; Lu Y; Li X
    J Drug Target; 2020 Feb; 28(2):129-141. PubMed ID: 31280623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of exosome-mimicking liposomes with conventional liposomes for intracellular delivery of siRNA.
    Lu M; Zhao X; Xing H; Xun Z; Zhu S; Lang L; Yang T; Cai C; Wang D; Ding P
    Int J Pharm; 2018 Oct; 550(1-2):100-113. PubMed ID: 30138707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and regulation of exosome-based therapy products.
    Batrakova EV; Kim MS
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016 Sep; 8(5):744-57. PubMed ID: 26888041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in exosome-based nanovehicles as RNA interference therapeutic carriers.
    Maheshwari R; Tekade M; Gondaliya P; Kalia K; D'Emanuele A; Tekade RK
    Nanomedicine (Lond); 2017 Nov; 12(21):2653-2675. PubMed ID: 28960165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNAi delivery by exosome-mimetic nanovesicles - Implications for targeting c-Myc in cancer.
    Lunavat TR; Jang SC; Nilsson L; Park HT; Repiska G; Lässer C; Nilsson JA; Gho YS; Lötvall J
    Biomaterials; 2016 Sep; 102():231-8. PubMed ID: 27344366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virus-modified exosomes for targeted RNA delivery; a new approach in nanomedicine.
    Koppers-Lalic D; Hogenboom MM; Middeldorp JM; Pegtel DM
    Adv Drug Deliv Rev; 2013 Mar; 65(3):348-56. PubMed ID: 22820525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.